NO983283D0 - Hydrokamsyre-baserte Kollagenase-inhibitorer - Google Patents

Hydrokamsyre-baserte Kollagenase-inhibitorer

Info

Publication number
NO983283D0
NO983283D0 NO983283A NO983283A NO983283D0 NO 983283 D0 NO983283 D0 NO 983283D0 NO 983283 A NO983283 A NO 983283A NO 983283 A NO983283 A NO 983283A NO 983283 D0 NO983283 D0 NO 983283D0
Authority
NO
Norway
Prior art keywords
hydrocamic
acid
collagenase inhibitors
based collagenase
inhibitors
Prior art date
Application number
NO983283A
Other languages
English (en)
Other versions
NO983283L (no
Inventor
Stuart Bailey
Derek Richard Buckle
Andrew Faller
David Glynn Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO983283D0 publication Critical patent/NO983283D0/no
Publication of NO983283L publication Critical patent/NO983283L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO983283A 1996-01-17 1998-07-16 Hydrokamsyre-baserte Kollagenase-inhibitorer NO983283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601041.8A GB9601041D0 (en) 1996-01-17 1996-01-17 Novel compounds
PCT/EP1997/000196 WO1997026257A1 (en) 1996-01-17 1997-01-14 Hydroxamic acid based collagenase inhibitors

Publications (2)

Publication Number Publication Date
NO983283D0 true NO983283D0 (no) 1998-07-16
NO983283L NO983283L (no) 1998-09-16

Family

ID=10787226

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983283A NO983283L (no) 1996-01-17 1998-07-16 Hydrokamsyre-baserte Kollagenase-inhibitorer

Country Status (19)

Country Link
EP (1) EP0912545A1 (no)
JP (1) JP2000503312A (no)
KR (1) KR19990077325A (no)
CN (1) CN1213368A (no)
AR (1) AR005472A1 (no)
AU (1) AU725056B2 (no)
BR (1) BR9707024A (no)
CA (1) CA2242913A1 (no)
CZ (1) CZ222498A3 (no)
GB (1) GB9601041D0 (no)
HU (1) HUP9901022A3 (no)
IL (1) IL125381A0 (no)
NO (1) NO983283L (no)
NZ (1) NZ326352A (no)
PL (1) PL327820A1 (no)
TR (1) TR199801380T2 (no)
TW (1) TW462967B (no)
WO (1) WO1997026257A1 (no)
ZA (1) ZA97345B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9609795D0 (en) * 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
AU1960100A (en) * 1999-01-06 2000-07-24 Mcmaster University Method of preventing immune and hypersensitivity reactions
GB9922825D0 (en) * 1999-09-25 1999-11-24 Smithkline Beecham Biolog Medical use
WO2002006227A1 (fr) * 2000-07-18 2002-01-24 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de la metalloprotease matricielle
AU2003202093B2 (en) * 2001-07-02 2010-05-13 Aimsco Limited Treatment of MS with goat serum
EP1787986A4 (en) 2004-08-10 2007-08-22 Shizuoka Coffein Co Ltd HYDROXAMINE ACID DERIVATIVE AND MEDICAMENT THEREFORE AS AN ACTIVE COMPONENT
KR100844277B1 (ko) * 2005-04-29 2008-07-07 (주)아모레퍼시픽 히드록삼산 유도체 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
GB9504084D0 (en) * 1995-03-01 1995-04-19 British Biotech Pharm Synthesis of carboxylic and hydroxamic acid derivatives

Also Published As

Publication number Publication date
AR005472A1 (es) 1999-06-23
CN1213368A (zh) 1999-04-07
WO1997026257A1 (en) 1997-07-24
BR9707024A (pt) 1999-07-20
GB9601041D0 (en) 1996-03-20
CZ222498A3 (cs) 1999-03-17
TR199801380T2 (xx) 1998-10-21
NZ326352A (en) 2000-03-27
TW462967B (en) 2001-11-11
IL125381A0 (en) 1999-03-12
NO983283L (no) 1998-09-16
ZA97345B (en) 1998-07-16
PL327820A1 (en) 1999-01-04
HUP9901022A3 (en) 2001-11-28
CA2242913A1 (en) 1997-07-24
AU1443697A (en) 1997-08-11
JP2000503312A (ja) 2000-03-21
AU725056B2 (en) 2000-10-05
KR19990077325A (ko) 1999-10-25
EP0912545A1 (en) 1999-05-06
HUP9901022A2 (hu) 1999-07-28

Similar Documents

Publication Publication Date Title
ID19198A (id) Inhibitor metaloprotease heterosiklik
ID18416A (id) Inhibitor metaloprotease diheterosiklik
NO995433D0 (no) Protease-inhibitorer
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
NO20006717D0 (no) Proteaseinhibitorer
LV12150A (lv) Farneziltransferazes inhibitori
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
PT936912E (pt) Inibidores de cisteina protease
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
NO20000464D0 (no) Acykliske metalloprotease-inhibitorer
NO996578D0 (no) Urokinase-inhibitorer
NO974403L (no) Reversible proteasehemmere
PT956294E (pt) Inibidores da trombina
NO995434L (no) Proteaseinhibitorer
NO995435D0 (no) Protease-inhibitorer
NO990896D0 (no) Bidentate metalloproteaseinhibitorer
NO995268D0 (no) Proteaseinhibitorer
NO980643D0 (no) Propylendopeptidase inhibitorer
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
NO983283D0 (no) Hydrokamsyre-baserte Kollagenase-inhibitorer
DE69523450T2 (de) Inhibitor
DE69828361D1 (de) Apoptose-inhibitor
ATE282629T1 (de) Thrombininhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application